• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.71% Nasdaq Down 0.63%

    Biogen Inc. (BIIB)

    -NasdaqGS
    312.58 Down 2.23(0.71%) Sep 23, 4:00PM EDT
    |After Hours : 312.58 0.00 (0.00%) Sep 23, 6:02PM EDT
    Prev Close:314.81
    Open:312.58
    Bid:311.00 x 100
    Ask:319.00 x 100
    1y Target Est:344.61
    Beta:0.398444
    Next Earnings Date:26-Oct-16BIIB Earnings announcement
    Day's Range:312.11 - 317.32
    52wk Range:223.02 - 333.65
    Volume:881,641
    Avg Vol (3m):1,828,500
    Market Cap:68.49B
    P/E (ttm):18.26
    EPS (ttm):17.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BIIB

    Comparison

    Symbol% ChgMkt Cap
    BIIBDown 0.71%68.49B
    PFEUp 0.32%207.81B
    ABTDown 0.07%62.02B

    Key Statistics

    Forward P/E (1 yr):15.00
    P/S (ttm):6.14
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :20.10
    Quarterly EPS Est (Sep-16) :5.01
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):1.83

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback